Nabilone for Agitation in Severe Alzheimer's Disease
Current Treatment Approaches
- Non-pharmacological interventions, including providing predictable routines and simplifying tasks, should be tried first for patients with agitation in Alzheimer's disease, as recommended by the American Academy of Family Physicians 1
- Atypical antipsychotics, such as risperidone and olanzapine, are recommended for severe psychomotor agitation and combativeness, but with risks of extrapyramidal symptoms, according to the American Academy of Family Physicians 2
- SSRIs are considered first-line treatments for agitation in vascular cognitive impairment, as stated by the Alzheimer's Association 3
Monitoring and Safety Considerations
- Regular assessment of treatment response using quantitative measures is recommended by the American Psychiatric Association 4
- If no clinically significant response occurs after 4 weeks of adequate dosing, medication should be tapered and withdrawn, as advised by the American Psychiatric Association 4
Clinical Decision Algorithm
- The American Psychiatric Association recommends confirming that the patient has severe Alzheimer's disease with agitation that is severe, dangerous, and/or causing significant distress, and is resistant to traditional antipsychotics and non-pharmacological interventions 4
- Before initiating nabilone, the American Psychiatric Association suggests discussing potential risks and benefits with the patient and surrogate decision-maker, and establishing baseline measurements of agitation, cognition, and overall function 4
- The American Psychiatric Association advises monitoring for therapeutic response using validated measures like CMAI, and for sedation and cognitive changes 4
Management of Agitation in Alzheimer's Disease
Pharmacological Options
- The American Academy of Family Physicians recommends quetiapine (Seroquel) with an initial dosage of 12.5 mg twice daily and a maximum of 200 mg twice daily for agitation in Alzheimer's disease 5
- Atypical antipsychotics, including quetiapine, are recommended for control of severe psychomotor agitation and combativeness, but require caution due to potential side effects such as transient orthostasis 5
- Risperidone (Risperdal) and olanzapine (Zyprexa) are alternative atypical antipsychotics with initial dosages of 0.25 mg/day and 2.5 mg/day, respectively, and maximum dosages of 2-3 mg/day and 10 mg/day, respectively 5
- Trazodone may be useful for agitation in Alzheimer's disease with an initial dosage of 25 mg/day up to 200-400 mg/day 5
- The Alzheimer's association notes that antipsychotics increase the risk of death, likely from cardiac toxicities, and should be used with caution 6
- SSRIs are considered first-line pharmacological treatments for agitation in cognitive impairment, according to the Alzheimer's association 6